Chinese haematology specialist Lu Daopei Medical Group has closed over 500 million yuan ($72 million) in a Series B round of equity financing led by Singaporean state-owned firm Temasek Holdings, with participation from Bahrain-based alternative investment firm Investcorp, according to a statement on Tuesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
